Ruti Aga and the Six-Year Ban: When a Forged Prescription Outweighed the Banned Substance

Someone sent in an old prescription pad — the paper kind that small clinics still use for handwriting — and on it was the signature of a family member. The clinic printed on the corner of the pad replied that the signatory had never worked there for a single day. The second facility, the one the prescription was said to have come from, confirmed the document was not theirs. Three denials for one thin sheet of paper, and Ruti Aga got four more years.

The sanction runs from 10 September, six years in total. Two years for the presence of methylprednisolone in her sample; four years for tampering with evidence during results management. Had the story stopped at the sample, it would have closed at a number any lawyer could argue with. The sheet of paper closed it another way.

Aga is 32. She won the Tokyo Marathon in 2026 and finished runner-up three times at World Marathon Majors, the top tier of road racing. Across 2026–2026 she belonged to the world's leading group of women marathoners, not to the bench behind it. In March she won a half marathon in China; the time from that race was not disclosed in the statement issued by the Athletics Integrity Unit (AIU), World Athletics' integrity body.

From years of watching women's marathons, I know one thing about the start area: ten minutes before the gun, it is utterly silent. East African athletes sit with their knees drawn up on plastic sheeting, nobody speaks, and the only sounds are spikes scraping the road and breath held inside the chest. After the line, all that remains is the clock. Before it, everything is silence.

One point many reports blur: methylprednisolone is not an anabolic steroid. It is a synthetic glucocorticoid, class S9 in the WADA list, prohibited in-competition only, and classified as a Specified Substance — a category the anti-doping code accepts as more plausibly linked to inadvertent use or genuine treatment than other classes. Aga said she used it to treat a knee injury.

Place the two facts side by side: the most defensible substance in the catalogue, and a knee injury entirely real in the life of a woman who runs 42 kilometres. On those facts alone, this is the kind of case a valid TUE — or an honest declaration — could have settled. There was no TUE. And instead of declaring, someone chose to prescribe.

The AIU record leaves little empty space. The prescription was said to be signed by a family member with no medical registration. That person claimed to have used an old pad from a former workplace; the workplace confirmed nobody of that name had ever been on staff. The clinic named on the document denied issuing it. Every link was checked independently, and every link broke.

The heaviest penalty in this case was not imposed for the substance. It was imposed for the paper. Four years for tampering, served on top of two years for presence, under the rule that multiple violations run consecutively rather than concurrently. The sentence tripled, and the reason sits in the attempt to prove she had not taken anything.

That mechanism has a technical logic. Testing is only half the system; the other half is the ability to verify documents. If a forged prescription could stand, any athlete could buy a lighter sentence with a pad. The AIU cannot let medical paperwork become a market. So they verify directly with clinics, check professional registration, cross-reference staff lists — steps almost nobody took fifteen years ago and which are now default procedure.

One detail is hard to pass over: the forgery was clumsy. No elaborate fake clinic, no hired physician, no coherent chain of documents. An old pad and a relative. There is no sign here of a sophisticated doping operation. What shows through is a person with nobody to call.

I have read enough case files to recognise that pattern. It appears among athletes managed by a single agent, racing a schedule the agent sets, with no independent legal counsel. When a sample comes back positive, the first call usually goes to a relative rather than a lawyer. And the relative does the only thing they can think of.

Another gap in the record: the route of administration was not stated. If it was an intra-articular injection close to competition, the in-competition prohibition is triggered automatically without a TUE — and an athlete who understood the rules would know to seek approval first. That she did not know, or was never told, changes nothing legally, but it explains how a treatment error slid into a paperwork offence.

The road-racing economy does the rest. Chinese half marathons and marathons in recent years have drawn East African athletes with appearance fees: a high volume of races, thinner testing density than the Majors, and constant pressure to keep showing up to keep earning. An athlete at 32, at the very top of her earning window, has a very practical reason to pick a race like that over a Major. The March result is almost certainly annulled, along with its prize money.

The career arithmetic is simpler. Six years from 10 September returns her to eligibility at roughly 38. Women's marathoning can stretch into the late thirties, but a return to Major podium level after six years without racing is a very small probability. At 32, Aga was inside the peak window, not past it. The ban lands exactly on the point of maximum value in an athlete's life.

There is a line I have written many times in thirteen years: "She does not need a medal to prove she won." This time I could not write it. Aga won Tokyo in 2026, and nobody can take that day from her. But the line exists to lift someone the system undervalues, not to excuse someone who put forged documents into a file. Using it here would be an abuse of kindness.

The more interesting question sits elsewhere. The system is broadcasting a clear message: if you make a treatment error, declare it immediately, the penalty will be far lighter than concealment. That message is legally correct. It only works for someone who has a person to explain it before panic sets in. Aga had no such person. The price of having nobody was four extra years.

Another reflex needs blocking. After cases like this, a familiar suspicion rises: is this a systemic problem in Ethiopian athletics? The evidence in the file does not say so. Ethiopia's road-running system is deep enough that one athlete's removal leaves almost no gap on the national record board. A single, clumsily handled individual case is not proof of an organised scheme.

What deserves real criticism is the telling. A women's case, with the details of a fake doctor who was a relative and a clinic that does not exist, travels far faster than a men's case of equal standing, which is usually framed as a procedural technicality. One act, two readings. Women's sport does not need saving; it needs to be seen — even when what must be seen is a forged prescription.

And I have to look at my own work. In Tokyo in 2026 I wrote that crying on the field is also a kind of victory. That was true in the locker room that day. It is not true here. Some tears open nothing, and a writer needs the nerve not to turn them into a paper medal.

The relative who signed that prescription may face separate consequences, professional and reputational, at a level the AIU file does not reach. The management layer around Aga will not escape scrutiny either. Forgery cases rarely involve one hand, and the AIU's ability to reconstruct the entire documentary chain shows they have the tools to go further if they choose. One possibility has not been excluded: retrospective review of older samples, biological passport included, now that a tampering finding exists.

In my drawer there is a file on Tokyo 2026. I write biographies, but what I am really doing is keeping the races nobody scored in — and now there is a footnote in it I do not yet know where to place. The day she crossed the line in Tokyo was real. The six-year ban is also real. The two do not cancel each other, and a decent writer has to hold both at once rather than pick the easier side.

The moral lesson has already been written by other people. What is missing is a helpline fast enough for an athlete to call before she opens a prescription pad, and a sport willing to pay for it. Until that exists, there will be more 32-year-old women standing between a start line and a sheet of paper, choosing wrong.